We're #hiring! Check out our newest opportunity below to apply if interested or share with your network. #biotechjobs #celltherapy #lifesciences
Kincell Bio
Pharmaceutical Manufacturing
Gainesville, Florida 3,364 followers
Engineering cells into therapies.
About us
Kincell is a technology-forward contract development and manufacturing organization (CDMO) that streamlines analytical development, process development, CMC consulting and GMP cell therapy manufacturing. Our focus is on developing and manufacturing immune cell therapies, including autologous and allogeneic CAR-T, CAR-NK, and CAR-M programs. For more information, please visit our website at www.kincellbio.com.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Gainesville, Florida
- Type
- Privately Held
- Founded
- 2023
- Specialties
- non-viral delivery technologies, early phase cell therapy, manufacturing GMP grade, and CMC support
Locations
-
Primary
Gainesville, Florida, US
Employees at Kincell Bio
Updates
-
If you're joining us at Meeting on the Mesa, please reach out to Bruce Thompson and Jessica Carmen and connect. We’re always excited to learn what you're interested in, talk about our capabilities, or just geek out on cool science!
-
Kincell Bio was honored to sponsor and attend Emily Whitehead Foundation's Believe Ball this past weekend. We were inspired to be surrounded by cancer warriors and their families, shoulder to shoulder with industry titans! #ActivateTheCure #EMF #EMFBelieveBall #CART #celltherapy #Innovation
-
We are pleased to announce that we have a new manufacturing client at our facility in Gainesville, Florida. It is always an honor to have an innovator chose Kincell for their manufacturing needs to support the treatment of their patients. #innovation #celltherapy #partnership #growth #lifesciences #CDMO Read more about this new partnership here, and learn more about all that we do at: https://kincellbio.com
-
We’re excited to be among the cell therapy teams attending the upcoming CAR-TCR Summit (https://ter.li/04sziw) in Boston! If you’re among them, please feel free to grab some time here (https://lnkd.in/er5GhmHe) with Jessica Carmen and Blaine Rathmannand connect. We’re always excited to talk about our capabilities (https://lnkd.in/eS8aVhev) or just geek out on cool science. #celltherapy #lifesciences #CDMO #innovation
-
We're #hiring! Check out our newest opportunity below to apply if interested or share with your network. #biotechjobs #celltherapy #lifesciences
-
Our team is delighted to welcome a new development and manufacturing client to facilities! We're excited to continue to help innovators bring new cellular therapies to market and support patients. #innovation #celltherapy #partnership #growth #lifesciences #CDMO Read more about our partnership here, and learn more about everything we do at https://kincellbio.com/
Kincell Bio expands production with new development and manufacturing partnership - Kincell Bio
https://kincellbio.com
-
We're thrilled to join our Imugene Limited partners in celebrating the promising results from their Phase 1b trials of Azer-cel! This is great news for the scientific and medical communities, and most importantly for patients and families of those with DLBCL. We're pleased to support the development of this life-changing therapy. Read more here: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://lnkd.in/eMWZM5_G
-
A huge congratulations to our partners at eXmoor Pharma! Their state-of-the-art advanced therapies manufacturing facility in Bristol has just been licensed by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), to manufacture GMP-grade cell and gene therapy materials for use in clinical trials. eXmoor now offers a full set of development, manufacturing, and consulting services to CGT innovators.
We are delighted to announce that we have secured our MIA(IMP) license from the MHRA for the manufacture of cell & gene therapies for clinical trials. Our 65,000 sq. ft Cell & Gene Therapy Centre provides GMP cleanrooms and fill finish capabilities for autologous & allogenic cell therapies, viral vectors, RNA and other technologies! “This marks the beginning of a new era of growth for eXmoor pharma, now offering a complete set of development, manufacturing and expert consulting services that support cell and gene therapy developers from research to the market,” said Angela Osborne, CEO. “As we develop new partnerships, we will expand GMP operations to pivotal and commercial scale within the facility that is designed to increase cleanroom capacity quickly and easily – but we will retain the same underlying commitment to collaboration and focus on achieving our client's goals.” https://lnkd.in/eUZ9uGPp
Press Release: eXmoor Pharma’s GMP cell and gene therapy manufacturing facility receives license from MHRA
https://www.exmoorpharma.com